Dr. Walee Chamulitrat
Wiss. Mitarbeiterin
(Klinik für Gastroenterologie, Hepatologie, Infektionskrankheiten, Vergiftungen)
Arbeitsgruppenleiterin
(AG Dr. Chamulitrat)
Ärztlicher / Beruflicher Werdegang
- seit 2003
Research Scientist at Internal Medicine IV (Department of Gastroenterology and Infectious Diseases), University Hospital Heidelberg, Heidelberg, Germany
- 2000 – 2003
Research Scientist at The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
- 1998 – 1999
Associate Professor (Research), Department of Physiology, LSU Medical Center, New Orleans, LA, USA
- 1995 – 1998
Assistant Professor (Research), Department of Physiology, LSU Medical Center, New Orleans, LA, USA
- 1990 – 1994
Visiting Fellow/Associate, Laboratory of Molecular Biophysics, NIEHS, NIH, Research Triangle Park, NC, USA
- 1988 – 1989
Visiting Fellow, Laboratory of Molecular Biophysics, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Research Triangle Park, NC, USA
Wissenschaftlicher Werdegang
- 1986 – 1988
Postdoctoral Fellow, U.S. Department of Agriculture, Agricultural Research Service, Philadelphia, PA, USA
Mitgliedschaften
- seit 2018
European Federation on Lipids
- 2014 – 2018
Phospholipid Research Center
- seit 2011
The Society for Experimental Biology and Medicine
- seit 2009
European Association for the Study of the Liver (EASL)
- 1992 – 2010
The Society for Free Radical Research -The Americas
- 2000 – 2010
The Society for Free Radical Research-European Region and Asia
- 1983 – 1999
The Society for Free Radical Research-European Region and Asia
- 1994 – 1999
American Association for the Advancement of Sciences
- 1994 – 1999
New York Academy of Sciences
- 1997 – 1999
Shock Society
- 1997 – 1999
Nitric Oxide Society
Research training and Interests
- Research training in 'Free radical biochemistry of oxygen-derived radicals and nitric oxide' in enzymatic systems, cells, and experimental animals.
- Development and mechanisms of actions of bile acid-phospholipid based drug for treatment of non-alcoholic fatty liver disease and steatohepatitis.
- The role of phospholipase A2 VIA (Pla2G6) inactivation on obesity and acute liver injury: use of tissue-specific knockout mice
- The role of fatty acid transport protein 4 inactivation in obesity, hyperlipidemia and hepatic immune response: use of tissue-specific knockout mice
Other Professional activities
- Served as a peer-reviewer for editors and associate editors of the following journals: Free Radical Biology & Medicine; Free Radical Research; Chemical Research in Toxicology; Biochemical Journal; Biochim. Biophys. Acta; Chemical Biological Interactions; American Journal of Physiology; Alcoholism: Clinical and Experimental Research; Life Sciences; Journal of Lipid Research; Journal of Investigative Dermatology; Journal Leukocyte Biology; International Journal of Cancer; Journal Pharmacology Experimental Therapeutics; Pharmaceutical Research; British Journal of Pharmacology; Experimental Biology and Medicine; Journal Cellular Molecular Medicine; Expert Opinion on Therapeutic Targets; Gut; JPET; Exp Biol Med ; Sci Report; Eur. J Pharmacol; Bio Pharm; J Genetics and Genome Res; Clin Sci; BBA lipids; Drug designs; Cell Signalling; Cell Biol International; Cell Phys Biochem; Exp Mol Phathol; FASEB J
- Served as an adhoc reviewer of three grants (1998-1999) for U.S. Department of Agriculture National Research Initiative Competitive Grants Program.
- Served as an abstract reviewer for The Oxygen Society (SFRR of the America).
- Served as a grant reviewer for The German Israel Foundation, The Czech Science Foundation, and Deutschforchungsgemeinschaft (DFG).
